nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CYP2C19—Sorafenib—thyroid cancer	0.157	0.231	CbGbCtD
Hexobarbital—CYP1A2—Sorafenib—thyroid cancer	0.145	0.213	CbGbCtD
Hexobarbital—CYP2C9—Sorafenib—thyroid cancer	0.131	0.192	CbGbCtD
Hexobarbital—CYP3A4—Vandetanib—thyroid cancer	0.126	0.185	CbGbCtD
Hexobarbital—CYP3A4—Sorafenib—thyroid cancer	0.0759	0.112	CbGbCtD
Hexobarbital—CYP3A4—Doxorubicin—thyroid cancer	0.046	0.0677	CbGbCtD
Hexobarbital—GABRA3—neck—thyroid cancer	0.0171	0.102	CbGeAlD
Hexobarbital—CHRNA7—neck—thyroid cancer	0.0144	0.0864	CbGeAlD
Hexobarbital—CHRFAM7A—trachea—thyroid cancer	0.0108	0.0643	CbGeAlD
Hexobarbital—CHRFAM7A—thyroid gland—thyroid cancer	0.00851	0.0509	CbGeAlD
Hexobarbital—GRIA2—head—thyroid cancer	0.00829	0.0496	CbGeAlD
Hexobarbital—GABRA3—thyroid gland—thyroid cancer	0.00815	0.0487	CbGeAlD
Hexobarbital—GABRA6—head—thyroid cancer	0.00801	0.0479	CbGeAlD
Hexobarbital—GABRA5—head—thyroid cancer	0.00777	0.0464	CbGeAlD
Hexobarbital—CHRFAM7A—head—thyroid cancer	0.00755	0.0452	CbGeAlD
Hexobarbital—GRIK2—head—thyroid cancer	0.00749	0.0448	CbGeAlD
Hexobarbital—GABRA3—head—thyroid cancer	0.00723	0.0432	CbGeAlD
Hexobarbital—GABRA4—head—thyroid cancer	0.00705	0.0421	CbGeAlD
Hexobarbital—CHRNA7—thyroid gland—thyroid cancer	0.00687	0.0411	CbGeAlD
Hexobarbital—CHRNA7—head—thyroid cancer	0.0061	0.0365	CbGeAlD
Hexobarbital—CHRNA4—head—thyroid cancer	0.00602	0.036	CbGeAlD
Hexobarbital—GABRA2—head—thyroid cancer	0.00539	0.0322	CbGeAlD
Hexobarbital—GABRA1—head—thyroid cancer	0.0052	0.0311	CbGeAlD
Hexobarbital—PTGS1—trachea—thyroid cancer	0.00395	0.0236	CbGeAlD
Hexobarbital—GABRA2—lymph node—thyroid cancer	0.00377	0.0225	CbGeAlD
Hexobarbital—CYP1A2—thyroid gland—thyroid cancer	0.00361	0.0216	CbGeAlD
Hexobarbital—CYP2E1—thyroid gland—thyroid cancer	0.00325	0.0194	CbGeAlD
Hexobarbital—PTGS1—thyroid gland—thyroid cancer	0.00313	0.0187	CbGeAlD
Hexobarbital—CYP2E1—head—thyroid cancer	0.00288	0.0172	CbGeAlD
Hexobarbital—PTGS1—head—thyroid cancer	0.00277	0.0166	CbGeAlD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00199	0.013	CbGpPWpGaD
Hexobarbital—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.00196	0.0128	CbGpPWpGaD
Hexobarbital—PTGS1—lymph node—thyroid cancer	0.00194	0.0116	CbGeAlD
Hexobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—thyroid cancer	0.00192	0.0126	CbGpPWpGaD
Hexobarbital—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00179	0.0117	CbGpPWpGaD
Hexobarbital—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00177	0.0116	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00173	0.0113	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00163	0.0107	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00162	0.0106	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00157	0.0103	CbGpPWpGaD
Hexobarbital—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.00153	0.01	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00151	0.00991	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.00134	0.00878	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00128	0.00841	CbGpPWpGaD
Hexobarbital—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.00127	0.00833	CbGpPWpGaD
Hexobarbital—GABRA6—Orphan transporters—RXRA—thyroid cancer	0.00123	0.00807	CbGpPWpGaD
Hexobarbital—GABRA4—Orphan transporters—RXRA—thyroid cancer	0.00122	0.00796	CbGpPWpGaD
Hexobarbital—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.0012	0.00786	CbGpPWpGaD
Hexobarbital—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00117	0.00768	CbGpPWpGaD
Hexobarbital—GABRA5—Orphan transporters—RXRA—thyroid cancer	0.00108	0.00708	CbGpPWpGaD
Hexobarbital—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00107	0.00701	CbGpPWpGaD
Hexobarbital—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00107	0.00701	CbGpPWpGaD
Hexobarbital—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00106	0.00697	CbGpPWpGaD
Hexobarbital—GABRA3—Orphan transporters—RXRA—thyroid cancer	0.00106	0.00695	CbGpPWpGaD
Hexobarbital—GABRA2—Orphan transporters—RXRA—thyroid cancer	0.00104	0.00683	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00103	0.00678	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00101	0.00658	CbGpPWpGaD
Hexobarbital—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000997	0.00653	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000945	0.00619	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000943	0.00618	CbGpPWpGaD
Hexobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000938	0.00615	CbGpPWpGaD
Hexobarbital—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000919	0.00602	CbGpPWpGaD
Hexobarbital—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000914	0.00599	CbGpPWpGaD
Hexobarbital—GABRA1—Orphan transporters—RXRA—thyroid cancer	0.000889	0.00582	CbGpPWpGaD
Hexobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—thyroid cancer	0.000881	0.00577	CbGpPWpGaD
Hexobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000854	0.00559	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000806	0.00528	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000795	0.00521	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000771	0.00505	CbGpPWpGaD
Hexobarbital—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000745	0.00488	CbGpPWpGaD
Hexobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000718	0.0047	CbGpPWpGaD
Hexobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000709	0.00465	CbGpPWpGaD
Hexobarbital—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000707	0.00463	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000705	0.00462	CbGpPWpGaD
Hexobarbital—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000705	0.00462	CbGpPWpGaD
Hexobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000696	0.00456	CbGpPWpGaD
Hexobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000647	0.00424	CbGpPWpGaD
Hexobarbital—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000643	0.00421	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000642	0.0042	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000622	0.00408	CbGpPWpGaD
Hexobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000597	0.00391	CbGpPWpGaD
Hexobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000589	0.00386	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000575	0.00377	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000563	0.00369	CbGpPWpGaD
Hexobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000553	0.00362	CbGpPWpGaD
Hexobarbital—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00055	0.0036	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—BRAF—thyroid cancer	0.00054	0.00354	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000539	0.00353	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.00053	0.00347	CbGpPWpGaD
Hexobarbital—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000524	0.00343	CbGpPWpGaD
Hexobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000524	0.00343	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000523	0.00343	CbGpPWpGaD
Hexobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000514	0.00337	CbGpPWpGaD
Hexobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000505	0.00331	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—BRAF—thyroid cancer	0.000492	0.00322	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000478	0.00313	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000478	0.00313	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000477	0.00313	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000472	0.00309	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000472	0.00309	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00047	0.00308	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000464	0.00304	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.00045	0.00295	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000449	0.00294	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000448	0.00293	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000443	0.0029	CbGpPWpGaD
Hexobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000431	0.00283	CbGpPWpGaD
Hexobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000431	0.00282	CbGpPWpGaD
Hexobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000426	0.00279	CbGpPWpGaD
Hexobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000424	0.00278	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000419	0.00275	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—CP—thyroid cancer	0.000419	0.00275	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—BRAF—thyroid cancer	0.000413	0.00271	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000412	0.0027	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000412	0.0027	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000412	0.0027	CbGpPWpGaD
Hexobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000408	0.00267	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000405	0.00265	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000405	0.00265	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000405	0.00265	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—BRAF—thyroid cancer	0.000401	0.00263	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000398	0.00261	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000396	0.00259	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000394	0.00258	CbGpPWpGaD
Hexobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000393	0.00257	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000389	0.00255	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000387	0.00253	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.00038	0.00249	CbGpPWpGaD
Hexobarbital—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000372	0.00243	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000358	0.00234	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000353	0.00231	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000346	0.00227	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000345	0.00226	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000345	0.00226	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—BRAF—thyroid cancer	0.000344	0.00225	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000339	0.00222	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—BRAF—thyroid cancer	0.000339	0.00222	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000339	0.00222	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000331	0.00217	CbGpPWpGaD
Hexobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.00033	0.00216	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000325	0.00213	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000324	0.00212	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000324	0.00212	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—HRAS—thyroid cancer	0.000323	0.00211	CbGpPWpGaD
Hexobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.00032	0.0021	CbGpPWpGaD
Hexobarbital—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000318	0.00208	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000314	0.00206	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CHST14—thyroid cancer	0.000311	0.00204	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000308	0.00202	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000305	0.002	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000303	0.00198	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—BRAF—thyroid cancer	0.000302	0.00198	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000301	0.00197	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000297	0.00194	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—BRAF—thyroid cancer	0.000296	0.00194	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000296	0.00194	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000295	0.00193	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—BRAF—thyroid cancer	0.000291	0.00191	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.000291	0.00191	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—AKT1—thyroid cancer	0.000285	0.00187	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000278	0.00182	CbGpPWpGaD
Hexobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000274	0.0018	CbGpPWpGaD
Hexobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000271	0.00177	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000264	0.00173	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000264	0.00173	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000259	0.0017	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000258	0.00169	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000254	0.00167	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000253	0.00166	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—HPGD—thyroid cancer	0.000251	0.00164	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—HRAS—thyroid cancer	0.000249	0.00163	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—BRAF—thyroid cancer	0.000248	0.00163	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000248	0.00162	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NDUFA13—thyroid cancer	0.000247	0.00162	CbGpPWpGaD
Hexobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000241	0.00158	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000241	0.00158	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000238	0.00156	CbGpPWpGaD
Hexobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000236	0.00155	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CHST14—thyroid cancer	0.000232	0.00152	CbGpPWpGaD
Hexobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000232	0.00152	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000227	0.00149	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—HRAS—thyroid cancer	0.000226	0.00148	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000224	0.00147	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000217	0.00142	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000206	0.00135	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000205	0.00134	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000204	0.00133	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000203	0.00133	CbGpPWpGaD
Hexobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000198	0.0013	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000193	0.00127	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000191	0.00125	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—HRAS—thyroid cancer	0.00019	0.00124	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—HPGD—thyroid cancer	0.000187	0.00123	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—HRAS—thyroid cancer	0.000184	0.00121	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000184	0.0012	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000181	0.00119	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000179	0.00118	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000178	0.00116	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000175	0.00115	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000175	0.00114	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.000174	0.00114	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CHST14—thyroid cancer	0.000164	0.00107	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—HRAS—thyroid cancer	0.000158	0.00104	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—HRAS—thyroid cancer	0.000156	0.00102	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000149	0.000976	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000149	0.000974	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000145	0.000947	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—TPR—thyroid cancer	0.000144	0.000944	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PRKAR1A—thyroid cancer	0.000142	0.000928	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CHST14—thyroid cancer	0.00014	0.000916	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—HRAS—thyroid cancer	0.000139	0.000908	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—HRAS—thyroid cancer	0.000136	0.000892	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000135	0.000884	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—HRAS—thyroid cancer	0.000134	0.000877	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—HPGD—thyroid cancer	0.000132	0.000864	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000128	0.000841	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000117	0.000768	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000115	0.000752	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—HRAS—thyroid cancer	0.000114	0.000748	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—HPGD—thyroid cancer	0.000113	0.000738	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CHST14—thyroid cancer	0.000108	0.000707	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—SLC5A5—thyroid cancer	0.000108	0.000706	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TPR—thyroid cancer	0.000108	0.000705	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000107	0.000701	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	0.000106	0.000694	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000101	0.000662	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.14e-05	0.000599	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—RXRA—thyroid cancer	9.06e-05	0.000593	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.81e-05	0.000577	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—HPGD—thyroid cancer	8.69e-05	0.00057	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TPR—thyroid cancer	8.3e-05	0.000544	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	8.17e-05	0.000535	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—SLC5A5—thyroid cancer	8.06e-05	0.000528	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TPR—thyroid cancer	7.57e-05	0.000496	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	7.45e-05	0.000488	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.4e-05	0.000485	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—RXRA—thyroid cancer	6.77e-05	0.000443	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.75e-05	0.000442	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TPR—thyroid cancer	6.47e-05	0.000424	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	6.37e-05	0.000417	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SLC5A5—thyroid cancer	6.22e-05	0.000407	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.82e-05	0.000382	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.77e-05	0.000378	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PPARG—thyroid cancer	5.72e-05	0.000375	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SLC5A5—thyroid cancer	5.67e-05	0.000371	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.31e-05	0.000348	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—RXRA—thyroid cancer	5.22e-05	0.000342	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.08e-05	0.000333	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TPR—thyroid cancer	4.99e-05	0.000327	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.91e-05	0.000322	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SLC5A5—thyroid cancer	4.84e-05	0.000317	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—RXRA—thyroid cancer	4.76e-05	0.000312	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.63e-05	0.000303	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.54e-05	0.000297	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PTGS2—thyroid cancer	4.5e-05	0.000295	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PPARG—thyroid cancer	4.27e-05	0.00028	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—RXRA—thyroid cancer	4.07e-05	0.000267	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.96e-05	0.000259	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PTEN—thyroid cancer	3.92e-05	0.000257	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.74e-05	0.000245	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PTGS2—thyroid cancer	3.36e-05	0.00022	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PPARG—thyroid cancer	3.3e-05	0.000216	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—RXRA—thyroid cancer	3.14e-05	0.000206	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PPARG—thyroid cancer	3.01e-05	0.000197	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PTEN—thyroid cancer	2.93e-05	0.000192	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PTGS2—thyroid cancer	2.59e-05	0.00017	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PPARG—thyroid cancer	2.57e-05	0.000168	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PTGS2—thyroid cancer	2.37e-05	0.000155	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PTEN—thyroid cancer	2.26e-05	0.000148	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—AKT1—thyroid cancer	2.26e-05	0.000148	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PTEN—thyroid cancer	2.06e-05	0.000135	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.02e-05	0.000132	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PPARG—thyroid cancer	1.98e-05	0.00013	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PTEN—thyroid cancer	1.76e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—AKT1—thyroid cancer	1.69e-05	0.000111	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.56e-05	0.000102	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PTEN—thyroid cancer	1.36e-05	8.91e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—AKT1—thyroid cancer	1.3e-05	8.54e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—AKT1—thyroid cancer	1.19e-05	7.79e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—AKT1—thyroid cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—AKT1—thyroid cancer	7.84e-06	5.14e-05	CbGpPWpGaD
